Clinical features of APS patients
| . | P1 . | P2 . | P3 . | P4 . | P5 . | Control . |
|---|---|---|---|---|---|---|
| Thrombotic events | Arterial and venous | Stroke | Arterial and venous | Stroke | Stroke | None |
| Lupus anticoagulant | + | + | ND | ND | + | — |
| Anti-β2GP1 IgG (SGU) | 199 | 197 | 140 | 23 | 186 | <5 |
| . | P1 . | P2 . | P3 . | P4 . | P5 . | Control . |
|---|---|---|---|---|---|---|
| Thrombotic events | Arterial and venous | Stroke | Arterial and venous | Stroke | Stroke | None |
| Lupus anticoagulant | + | + | ND | ND | + | — |
| Anti-β2GP1 IgG (SGU) | 199 | 197 | 140 | 23 | 186 | <5 |
Clinical features of patients and healthy individuals (controls).
ND, not determined; P, patient number; SGU, standard IgG units.